GO:0032452 histone demethylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032452 histone demethylase activity is defined as catalysis of the removal of a methyl group from a histone.
• LSD1 (KDM1A) was the first identified histone demethylase, demonstrating that histone methylation is reversible.
• JmjC-domain enzymes such as KDM5B, KDM5D, and KDM6A use distinct catalytic mechanisms to demethylate specific histone lysine residues [1,5,7].
• Histone demethylases regulate transcription, inflammation, cancer progression, and viral reactivation [1,2,3,5,6,7].
• Dysregulated histone demethylase activity is implicated in epithelial malignancies, kidney cancer, osteoarthritis, and inflammatory diseases [1,3,6,7].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential for dissecting demethylase function and therapeutic potential [1,2,3,5,6,7].
Description
Histone demethylase activity (GO:0032452) is a molecular function that catalyzes the removal of a methyl group from a histone. This activity is fundamental to epigenetic regulation because it reverses histone methylation, a modification historically considered stable and irreversible. The discovery of LSD1 (KDM1A) as a nuclear amine oxidase homolog capable of demethylating histone H3 lysine 4 (H3K4) established that histone methylation is dynamically regulated. Since then, multiple histone demethylase families have been identified, including the JmjC-domain-containing enzymes such as KDM5B, KDM5D, and KDM6A, which demethylate specific lysine residues on histones H3 and H4 [1,5,7]. These enzymes are critical for gene expression programs controlling development, immunity, and disease [1,2,3,5,6,7]. Researchers study histone demethylase activity to understand how chromatin modifications influence transcription, cell fate, and disease pathogenesis [1,2,3,5,6,7]. For example, KDM5B is hijacked by Epstein-Barr virus to drive epithelial malignancy progression, while LSD1 regulates kidney cancer progression by modulating androgen receptor activity. In macrophages, KDM5B licenses inflammatory responses by repressing Nfkbia transcription. KDM5D mediates p38alpha inactivation to inhibit cancer progression, and inhibition of KDM6A promotes chondrocytic activity and attenuates osteoarthritis development. These findings highlight the broad physiological and pathological relevance of histone demethylase activity. Understanding GO:0032452 is therefore essential for researchers in epigenetics, cancer biology, immunology, and drug discovery. The activity is tightly regulated by metabolic cues and cofactors, and its dysregulation contributes to multiple human diseases [1,3,5,6,7,8]. This article provides a comprehensive overview of the definition, mechanism, key genes, disease associations, and research methods for studying histone demethylase activity, with a focus on CRISPR-based models for functional validation.
histone demethylase activity At A Glance
| GO ID | GO:0032452 |
|---|---|
| GO term | histone demethylase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of the removal of a methyl group from a histone |
| Catalytic mechanism | Oxidative demethylation (JmjC domain) or amine oxidation (LSD1) |
| Substrates | Methylated histone lysine residues (e.g., H3K4me1/2, H3K9me1/2, H3K27me1/2) [4,5,7] |
| Cofactors | FAD (LSD1), alpha-ketoglutarate, Fe(II), and oxygen (JmjC enzymes) |
| Key families | LSD/KDM1 family, JmjC-domain KDM family |
What Is GO:0032452?
GO:0032452 histone demethylase activity is a molecular function defined as the catalysis of the removal of a methyl group from a histone. This activity is carried out by enzymes that target specific methylated lysine or arginine residues on histone proteins, thereby altering chromatin structure and gene expression. The reaction typically involves oxidative demethylation for JmjC-domain enzymes or amine oxidation for flavin-dependent amine oxidases like LSD1. This function is distinct from other histone-modifying activities such as histone methyltransferases, acetyltransferases, and deacetylases.
Why Is histone demethylase activity Important in Cell Biology?
Histone demethylase activity is critically important because it provides a reversible switch for histone methylation, enabling dynamic control of gene expression programs. This activity influences fundamental processes such as development, differentiation, immune responses, and viral latency [1,2,3,5,6,7]. Dysregulation of histone demethylases is linked to cancer, inflammatory diseases, and osteoarthritis, making them attractive therapeutic targets [1,3,5,6,7]. For researchers, understanding GO:0032452 is essential for interpreting epigenetic data and designing experiments to manipulate chromatin states.
• Reverses histone methylation, a key epigenetic mark for gene regulation.
• Regulates transcription factors and chromatin accessibility [1,3,5].
• Controls inflammatory gene programs in macrophages.
• Modulates cancer progression and tumor suppression [1,5,6].
• Influences viral latency and reactivation, including Epstein-Barr virus [1,2].
• Plays a role in osteoarthritis and chondrocyte function.
• Is regulated by metabolic cues such as temperature in plants.
• Serves as a target for small-molecule inhibitors in cancer therapy [6,7].
• Enables dynamic epigenetic reprogramming during development.
• Provides a mechanism for environmental adaptation via chromatin modification.
Mechanism, Genes and Research Methods of histone demethylase activity
Substrate Recognition and Binding
In simple terms: The enzyme first finds and binds to the methylated histone mark it needs to remove.
Histone demethylases recognize specific methylated lysine residues on histone tails through their catalytic domains and auxiliary reader domains. For example, LSD1 (KDM1A) binds to H3K4me1/2 through its amine oxidase domain and requires association with corepressor complexes for substrate specificity. JmjC-domain enzymes such as KDM5B and KDM5D recognize H3K4me2/3 and H3K9me2/3, respectively, through their PHD and JmjC domains [1,5]. KDM6A targets H3K27me2/3 via its JmjC domain. This substrate recognition is essential for the precise regulation of gene expression [4,5,7].
Catalytic Demethylation Reaction
In simple terms: The enzyme chemically removes the methyl group from the histone.
LSD1 catalyzes demethylation through an FAD-dependent amine oxidation reaction, producing formaldehyde and hydrogen peroxide. In contrast, JmjC-domain enzymes such as KDM5B, KDM5D, and KDM6A use an Fe(II)- and alpha-ketoglutarate-dependent oxidative demethylation mechanism, generating succinate, formaldehyde, and CO2 [1,5,7]. These distinct mechanisms allow for differential regulation and inhibitor design [4,5,7].
Chromatin Remodeling and Transcriptional Output
In simple terms: Removing the methyl mark changes how genes are turned on or off.
Demethylation of repressive marks such as H3K9me2/3 or H3K27me2/3 typically leads to transcriptional activation, while removal of active marks like H3K4me2/3 can repress transcription [4,5,7]. For instance, KDM5B represses Nfkbia transcription by demethylating H3K4me3 at its promoter, thereby licensing inflammatory responses. KDM5D demethylates H3K9me3 to inactivate p38alpha signaling and inhibit cancer progression. KDM6A inhibition increases H3K27me3 at the Wnt10a promoter, promoting chondrocytic activity.
Regulation by Cofactors and Metabolism
In simple terms: The enzyme's activity depends on available metabolites and cofactors.
JmjC-domain demethylases require alpha-ketoglutarate, Fe(II), and oxygen as cofactors, making their activity sensitive to cellular metabolic states [4,8]. In plants, histone demethylase activity is metabolically controlled in response to high temperature. LSD1 requires FAD as a cofactor, linking its activity to cellular redox status. This metabolic coupling allows histone demethylases to act as sensors of the cellular environment [4,8].
Protein-Protein Interactions and Complex Assembly
In simple terms: Demethylases often work in teams with other proteins to do their job.
LSD1 functions within multiprotein complexes such as CoREST and NuRD to achieve substrate specificity and stable chromatin association. KDM5B interacts with transcriptional repressors and chromatin modifiers to regulate macrophage inflammatory responses. KDM6A is part of the MLL3/4 COMPASS-like complex that coordinates H3K27 demethylation with H3K4 methylation. These interactions are critical for the biological specificity of histone demethylase activity [3,4,7].
Key Genes Involved in GO:0032452 histone demethylase activity
The following genes encode histone demethylases or associated proteins that directly mediate or regulate GO:0032452 histone demethylase activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KDM1A (LSD1) | Flavin-dependent amine oxidase that demethylates H3K4me1/2 and H3K9me1/2 | First identified histone demethylase; regulates kidney cancer and androgen receptor activity [4,6] |
| KDM5B (JARID1B) | JmjC-domain demethylase targeting H3K4me2/3 [1,3] | Hijacked by Epstein-Barr virus; licenses macrophage inflammation [1,3] |
| KDM5D | JmjC-domain demethylase targeting H3K9me2/3 | Mediates p38alpha inactivation to inhibit cancer progression |
| KDM6A (UTX) | JmjC-domain demethylase targeting H3K27me2/3 | Inhibition promotes chondrocytic activity and attenuates osteoarthritis |
| KDM2A | JmjC-domain demethylase targeting H3K36me2 | Involved in ribosomal RNA transcription and cell cycle regulation |
| KDM3A | JmjC-domain demethylase targeting H3K9me1/2 | Regulates spermatogenesis and cancer progression |
| KDM4A | JmjC-domain demethylase targeting H3K9me2/3 and H3K36me2/3 | Implicated in cancer and genome stability |
| KDM4B | JmjC-domain demethylase targeting H3K9me2/3 | Regulates androgen receptor signaling and DNA repair |
| KDM4C | JmjC-domain demethylase targeting H3K9me2/3 | Amplified in cancer; regulates stem cell self-renewal |
| KDM5A | JmjC-domain demethylase targeting H3K4me2/3 | Involved in drug tolerance and cancer stem cells |
| KDM5C | JmjC-domain demethylase targeting H3K4me2/3 | Mutated in X-linked intellectual disability |
| KDM6B (JMJD3) | JmjC-domain demethylase targeting H3K27me2/3 | Regulates inflammation and macrophage polarization |
| KDM7A | JmjC-domain demethylase targeting H3K9me1/2 and H4K20me1 | Involved in neuronal differentiation |
| PHF8 | JmjC-domain demethylase targeting H3K9me1/2 and H4K20me1 | Linked to X-linked mental retardation |
| JARID2 | JmjC-domain protein with no demethylase activity; recruits PRC2 | Regulates embryonic development and gene silencing |
| RBP2 (KDM5A) | JmjC-domain demethylase targeting H3K4me2/3 | Regulates cellular senescence and differentiation |
| UTY | JmjC-domain demethylase targeting H3K27me3 | Y-linked homolog of KDM6A; involved in sex determination |
| JMJD1C | JmjC-domain demethylase targeting H3K9me1/2 | Regulates thyroid hormone receptor and spermatogenesis |
How Is histone demethylase activity Regulated?
Histone demethylase activity is regulated at multiple levels, including cofactor availability, post-translational modifications, protein-protein interactions, and metabolic signals [4,8]. JmjC-domain enzymes depend on alpha-ketoglutarate, Fe(II), and oxygen, making their activity sensitive to cellular metabolism and hypoxia [4,8]. In plants, histone demethylase activity is metabolically controlled in response to high temperature, demonstrating environmental regulation. LSD1 activity is regulated by FAD availability and its association with corepressor complexes such as CoREST. Additionally, histone demethylases can be regulated by phosphorylation, ubiquitination, and sumoylation, although specific examples are beyond the scope of this article.
histone demethylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KDM5B | Epithelial malignancy progression driven by Epstein-Barr virus | Knockout or overexpression in EBV-infected epithelial cells |
| KDM5D | Cancer progression inhibition via p38alpha inactivation | Point mutation of catalytic residue in cancer cell lines |
| LSD1 (KDM1A) | Kidney cancer progression and androgen receptor signaling | Knockout in renal cancer cell lines and xenografts |
| KDM6A | Osteoarthritis and chondrocyte activity | Knockout or inhibitor treatment in chondrocytes |
| KDM5B | Macrophage-mediated inflammatory responses | Conditional knockout in macrophages |
Histone Demethylases in Cancer
Dysregulated histone demethylase activity is a hallmark of multiple cancers [1,5,6]. KDM5B is upregulated by Epstein-Barr virus to drive epithelial malignancy progression, promoting tumor growth and metastasis. KDM5D mediates p38alpha inactivation via its enzymatic activity to inhibit cancer progression, suggesting a tumor-suppressive role. LSD1 regulates kidney cancer progression by modulating androgen receptor activity, and its inhibition reduces tumor growth. These findings highlight histone demethylases as potential therapeutic targets in oncology [1,5,6].
Histone Demethylases in Inflammatory Diseases
KDM5B licenses macrophage-mediated inflammatory responses by repressing Nfkbia transcription, thereby promoting NF-kappaB activation. This function is critical for host defense but can also contribute to chronic inflammatory diseases. LSD1 and KDM6B also regulate inflammatory gene programs in macrophages and other immune cells. Targeting these demethylases may provide new strategies for treating inflammatory disorders [3,4].
Histone Demethylases in Osteoarthritis
Inhibition of KDM6A promotes chondrocytic activity and attenuates osteoarthritis development through repressing H3K27me3 enhancement of Wnt10a. This suggests that KDM6A inhibitors could be developed as disease-modifying therapies for osteoarthritis. The role of other demethylases in cartilage biology remains an active area of research.
Histone Demethylases in Viral Infection
Epstein-Barr virus hijacks histone demethylase machinery, specifically KDM5B, to drive epithelial malignancy progression. Conversely, the lysine-specific histone demethylase complex restricts Epstein-Barr virus lytic reactivation, indicating a complex interplay between viral proteins and host demethylases. These findings suggest that modulating demethylase activity could influence viral latency and associated malignancies [1,2].
From histone demethylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of demethylase activity affect tumor growth? | CRISPR knockout of KDM5B or KDM5D in cancer cell lines [1,5] |
| Is the catalytic activity required for function? | Point mutation of catalytic residues (e.g., JmjC domain) |
| Does a specific histone mark drive disease? | Knock-in of methyl-mimic or unmethylable histone mutants |
| Where does the demethylase localize in cells? | Tagged knock-in with GFP or HA epitope |
| Can overexpression mimic disease phenotype? | Overexpression of KDM5B in epithelial cells |
| What genes are regulated by demethylase activity? | CRISPR knockout followed by RNA-seq [3,7] |
How to Study the histone demethylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-qPCR | Histone methylation at specific loci | Validate demethylase target genes [3,7] |
| ChIP-seq | Genome-wide histone methylation and binding | Map epigenetic changes after knockout |
| Western blot | Global histone methylation levels | Assess demethylase activity in cells [1,5,7] |
| Immunofluorescence | Histone marks in situ | Correlate marks with cellular phenotypes |
| In vitro activity assay | Enzymatic demethylation of peptides | Measure kinetics and inhibitor efficacy |
| RNA-seq | Transcriptional changes | Identify downstream pathways [3,7] |
| Mass spectrometry | Demethylated peptide products | Confirm substrate specificity |
| CRISPR screening | Genes required for demethylase function | Identify synthetic lethal interactions |
Chromatin Immunoprecipitation (ChIP) and ChIP-seq
ChIP is used to measure the abundance of specific histone methylation marks at genomic loci, thereby inferring histone demethylase activity [3,5,7]. For example, KDM5B knockout increases H3K4me3 at the Nfkbia promoter, which can be detected by ChIP-qPCR. KDM6A inhibition increases H3K27me3 at the Wnt10a promoter. ChIP-seq provides genome-wide maps of histone modifications and demethylase binding sites.
Western Blot and Immunofluorescence
Western blot with antibodies against specific histone methylation marks (e.g., H3K4me3, H3K9me3, H3K27me3) is a standard method to assess global changes in histone demethylase activity [1,5,7]. Immunofluorescence can visualize these marks in situ and correlate them with cellular phenotypes. These methods are often used to validate CRISPR knockout or point-mutation effects [1,5,7].
Enzymatic Activity Assays
In vitro demethylase activity assays use recombinant enzymes, methylated histone peptides, and cofactors (e.g., alpha-ketoglutarate, Fe(II), FAD) to measure the release of formaldehyde or the formation of demethylated products. These assays are essential for determining kinetic parameters and testing inhibitors. Mass spectrometry-based assays can also detect demethylation of histone peptides.
RNA-seq and Transcriptomics
RNA-seq is used to identify genes whose expression changes upon modulation of histone demethylase activity [3,7]. For example, KDM5B knockout alters the expression of inflammatory genes in macrophages, and KDM6A inhibition changes Wnt10a expression in chondrocytes. Transcriptomics provides a global view of the biological consequences of demethylase activity [3,7].
How CRISPR Can Be Used to Study GO:0032452 histone demethylase activity
Knockout
CRISPR knockout is widely used to eliminate histone demethylase genes and assess their loss-of-function phenotypes [1,3,5,6,7]. For example, KDM5B knockout in macrophages reduces inflammatory responses, and KDM6A knockout in chondrocytes increases H3K27me3 and promotes chondrocytic activity. Knockout of LSD1 in kidney cancer cells inhibits proliferation and androgen receptor signaling. These models are essential for validating the causal role of demethylase activity in disease [1,3,5,6,7].
Point Mutation
Point mutations in catalytic residues (e.g., JmjC domain or FAD-binding site) are used to separate enzymatic activity from scaffolding functions. For instance, mutation of the catalytic residue in KDM5D abolishes its ability to inactivate p38alpha and inhibit cancer progression. Such models are critical for determining whether demethylase activity is required for a specific phenotype.
Knock-in
Knock-in of tagged demethylases (e.g., GFP, HA, or BirA) allows for localization, interaction, and chromatin binding studies. Knock-in of histone mutants (e.g., H3K4A or H3K27A) can mimic or block demethylation at specific residues. These models provide precise tools for dissecting demethylase function in vivo.
Overexpression
Overexpression of histone demethylases such as KDM5B is used to model gain-of-function phenotypes observed in cancer. For example, KDM5B overexpression in epithelial cells promotes malignancy progression in the context of Epstein-Barr virus infection. Overexpression models help identify downstream pathways and potential therapeutic vulnerabilities.
How EDITGENE Supports histone demethylase activity Research
Researchers studying histone demethylase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as cancer progression, inflammatory responses, or chondrocyte differentiation. CRISPR-based models provide the most direct way to establish causality by manipulating the gene of interest and measuring the consequences on histone methylation and gene expression. EDITGENE offers a comprehensive suite of services to support these studies, from knockout and point-mutation cell lines to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for histone demethylase activity research.
Frequently Asked Questions About histone demethylase activity
What is histone demethylase activity?
Histone demethylase activity (GO:0032452) is the catalysis of the removal of a methyl group from a histone, a key epigenetic modification that regulates gene expression.
What genes are involved in histone demethylase activity?
Key genes include KDM1A (LSD1), KDM5B, KDM5D, KDM6A, KDM4A, and many other JmjC-domain-containing enzymes [1,3,4,5,7].
What is the function of GO:0032452?
GO:0032452 enables the removal of methyl groups from histone proteins, thereby reversing histone methylation and modulating chromatin structure and transcription.
Which enzyme was the first histone demethylase discovered?
LSD1 (KDM1A) was the first histone demethylase identified, demonstrating that histone methylation is reversible.
How is histone demethylase activity regulated?
It is regulated by cofactor availability (e.g., alpha-ketoglutarate, FAD), metabolic signals, protein-protein interactions, and post-translational modifications [4,8].
What diseases are associated with histone demethylase activity?
Dysregulated activity is linked to cancer, inflammatory diseases, osteoarthritis, and viral infections such as Epstein-Barr virus [1,2,3,5,6,7].
How can I study histone demethylase activity in the lab?
Common methods include ChIP-seq, western blot for histone marks, in vitro activity assays, RNA-seq, and CRISPR knockout or point-mutation models [3,4,5,7].
What is the difference between LSD1 and JmjC-domain demethylases?
LSD1 uses FAD-dependent amine oxidation, while JmjC-domain enzymes use Fe(II)- and alpha-ketoglutarate-dependent oxidative demethylation.
Can histone demethylases be targeted therapeutically?
Yes, inhibitors of LSD1 and KDM6A are being explored for cancer and osteoarthritis, respectively [6,7].
What CRISPR models are available for histone demethylase research?
Knockout, point-mutation, knock-in, tagged knock-in, and overexpression models can be generated to study demethylase function and disease relevance [1,3,5,6,7].
Conclusion
Histone demethylase activity (GO:0032452) is a fundamental epigenetic function that reverses histone methylation and controls gene expression programs critical for development, immunity, and disease. The discovery of LSD1 and subsequent identification of JmjC-domain enzymes have revealed a diverse family of demethylases with distinct substrate specificities and regulatory mechanisms [1,4,5,7]. Dysregulation of these enzymes contributes to cancer, inflammatory diseases, osteoarthritis, and viral pathogenesis, making them promising therapeutic targets [1,2,3,5,6,7]. Researchers can leverage CRISPR-based models, including knockout, point-mutation, knock-in, and overexpression cell lines, to dissect the causal roles of histone demethylases in health and disease. EDITGENE provides end-to-end services to support these studies, from custom cell line generation to CRISPR library screening and bioinformatics analysis. By combining rigorous experimental models with advanced epigenomic and transcriptomic methods, the field can continue to uncover the precise mechanisms and therapeutic potential of histone demethylase activity.
References
- 1. Zhou YQ et al.. 2025. Epstein-Barr virus hijacks histone demethylase machinery to drive epithelial malignancy progression through KDM5B upregulation.. Signal Transduct Target Ther 10(1):83 PMID: 40059116
- 2. Liao Y et al.. 2025. Lysine-specific histone demethylase complex restricts Epstein-Barr virus lytic reactivation.. Nat Microbiol 10(12):3290-3304 PMID: 41174223
- 3. Zhang Y et al.. 2023. Histone demethylase KDM5B licenses macrophage-mediated inflammatory responses by repressing Nfkbia transcription.. Cell Death Differ 30(5):1279-1292 PMID: 36914768
- 4. Shi Y et al.. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.. Cell 119(7):941-53 PMID: 15620353
- 5. Chen J et al.. 2024. KDM5D histone demethylase mediates p38α inactivation via its enzymatic activity to inhibit cancer progression.. Proc Natl Acad Sci U S A 121(50):e2402022121 PMID: 39636854
- 6. Lee KH et al.. 2020. Histone Demethylase LSD1 Regulates Kidney Cancer Progression by Modulating Androgen Receptor Activity.. Int J Mol Sci 21(17) PMID: 32847068
- 7. Lian WS et al.. 2023. Inhibition of histone lysine demethylase 6A promotes chondrocytic activity and attenuates osteoarthritis development through repressing H3K27me3 enhancement of Wnt10a.. Int J Biochem Cell Biol 158:106394 PMID: 36871937
- 8. Cui X et al.. 2021. Metabolic control of histone demethylase activity involved in plant response to high temperature.. Plant Physiol 185(4):1813-1828 PMID: 33793949
